Díaz LPMA, GJB, Díaz MCA, Briones GJC

Language: Spanish
References: 14
Page: 54-58
PDF size: 94.69 Kb.

ABSTRACT

Objective: Demonstrate that the service where it happens the biggest number of intrahospital pneumonias for P. aeruginosa it is the ICU for the methodology that is used for their treatment, besides an incorrect indication of antibiotics; since the report of the microbiologic studies is not used that are made in these areas by the epidemiology services and infectology every month where they report the existent germs in these areas specifying its sensibility and resistance. Design: Is an study transverse and analytic. Place: ICU of the Hospital of Specialties “Dr. Bernardo Sepúlveda” of the Center Medical National XXI Century. Patient: Sixty seven patients with intrahospital pneumonia for P. aeruginosa in the Hospital of Specialties “Dr. Bernardo Sepúlveda” CMN SXXI in the period understood among January 1 from the 2002 to, December 31 the 2002. Results: Of the 67 studied patients, 26 (39%) they received treatment for which were resistant, with a mortality of 65%, 17 (25%) they received treatment for which were sensitive, with mortality of 11%, 5 patients (7%) they received both treatments for resistant and sensitive with a mortality of 20%. Finally 19 patients (29%) they received another treatment type to which they were not sensitive but neither resistant reporting a mortality of 31%. Conclusions: The service where is presented with more frequency the intrahospital pneumonia for P. aeruginosa is the ICU. The treatment for this germ was not the appropriate in most of the patients, and the antimicrobial of first instance was not the suitable one being based on the monthly epidemic study. On the other hand when that of the appropriate characteristics was used or the one reported in the patient’s cultivations with the high sensibility and without resistance this diminished the mortality for this illness.

REFERENCES

1. Díaz de León PM, Briones GJ. Uso de antibióticos en la UCI, Sepsis Abdominal Grave. En: Aguirre GH. Actualidades Médico-Quirúrgicas. Ed. Prado México, 2000:313-320.

2. Teramoto S, Yamamoto H, Yamaguchi Y, Kawaguchi H, Ouchi Y. Nosocomial infections in adult intensive-care units. Lancet 2003;362(9382):493.

3. Erbay H, Yalcin AN, Serin S, Turgut H, Tomatir E, Cetin B, Zencir M. Nosocomial infections in intensive care unit in a Turkish University Hospital: a 2-year survey. Intensive Care Med 2003;29(9):1482-8.

4. Garnes JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control 1998;16:128-140.

5. Kang CI, Kim SH, Kim HB, Park SW, Choe YJ, Oh MD, Kim EC, Choe KW. Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin Infect Dis 2003;37(6):745-5.

6. Imahara SD, Nathens AB. Antimicrobial strategies in surgical critical care. Curr Opin Crit Care 2003;9(4):286-91.

7. Rello J, Lorente C, Diaz E, Bodi M, Boque C, Sandiumenge A, Santamaria JM. Incidence, etiology, and outcome of nosocomial pneumonia in ICU patients requiring percutaneous tracheotomy for mechanical ventilation. Chest 2003;124(6):2239-43.

8. Girou E. Prevention of nosocomial infections in acute respiratory failure patients. Eur Respir J Suppl 2003;42:72s-76s.

9. Zanetti G, Bally F, Greub G, Garbino J, Kinge T, Lew D, Romand JA, Bille J, Aymon D, Stratchounski L, Krawczyk L, Rubinstein E, Schaller MD, Chiolero R, Glauser MP, Cometta A. Cefepime Study Group, Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study. Antimicrob Agents Chemother 2003;47(11):3442-7.

10. West M, Boulanger BR, Fogarty C, Tennenberg A, Wiesinger B, Oross M, Wu SC, Fowler C, Morgan N, Kahn JB. Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: a multicenter, prospective, randomized, open-label study. Clin Ther 2003;25(2):485-506.

11. Gómez J, Alcántara M et al. Bacteriemias por Pseudomonas aeruginosa, clínica y tratamiento. Estudio prospectivo de siete años. Rev Esp Quimioterap 2002;15(4):360-365.

12. Yologlu S, Durmaz B, Bayindir Y. Nosocomial infections and risk factors in intensive care units. New Mcrobiol 2003;26(3):299-303.

13. Hoffken G, Niederman MS. Nosocomial pneumonia: the importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU. Chest 2002;122(6):2183-96.

14. Lorenz J, Bodmann KF, Bauer TT, Ewig S, Trautmann M, Vogel F. German Society for Anesthesiology and intensive Care (DGAI). Nosocomial pneumonia: prevention, diagnosis, treatment Pneumonologic. 2003;57(9):532-45.